medigraphic.com
ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C

2013, Number 1

<< Back Next >>

Rev Mex Periodontol 2013; 4 (1)

Interdisciplinary treatment in a patient with Sjögren's syndrome. Case report

Plaza UML, Soto CAA, Ramírez AMÁ, Ruiz GAC, Uehara N, Huerta CA

Language: Spanish
References: 24
Page: 24-30
PDF size: 416.62 Kb.


ABSTRACT

Sjögren’s syndrome is an autoimmune disease characterized by a chronic inflammation of exocrine glands whose phenotypic manifestation is keratoconjunctivitis sicca and xerostomia, prone to the development of rampant caries, periodontal disease and bacterial and fungal infections. There on, according to its manifestations, can be classified as primary or secondary, and such classification guide the treatment of choice, which in most cases is mainly symptomatic. Primary Sjögren’s syndrome has a population prevalence of 0.5 to 1%, universal geographic distribution and affects all races; however, predominates in women 9:1 in relation to men. Procedure: In this case report, the target was the point to the diagnosis and progression of interdisciplinary dental treatment of a patient with xerostomia and rampant caries. Based on medical and dental history, besides the anamnesis and clinical inspection, were based the following Results: In the medical history, the patient was diagnosed with Sjögren’s syndrome at 28 years of age and periodontal level presents localized chronic periodontitis plaque induced gingivitis associated with factors such as rampant decay and loss of tooth substance. Conclusions: The dental treatment of patients with SS is a difficult task because many elements can alter the course or treatment of the same. Therefore, knowledge of the nature of the relevant pathologies is essential to further various diagnostic and therapeutic strategies.


REFERENCES

  1. Aframian D, Konttinen Y, Carrozo M, Tzioufas A. Urban legends series: Sjögren´s syndrome. Oral Diseases. 2013; 19: 46–58.

  2. Jonsson R, Moen K, Vestheim D, Szodoray P. Current issues en Sjögren´s syndrome. Salivary glands and saliva. Oral Diseases. 2002; 8: 130-140.

  3. Nakagawa Y. Management of dry mouth in Sjögren´s syndrome. Jap Dent Science Rev. 2011; 47: 115-123.

  4. Bootsma H, Spijkervet F, Kroese F, Vissink A. Toward New Classification Criteria for Sjögren’s Syndrome?. Arthritis & Rheumatism. 2013; 65 (1): 21–23.

  5. Mathews S. Kurien B. and Scofiel R. Oral manifestations of Sjögren´s syndrome. J Dent Res. 2008; 87 (4): 308-318.

  6. Rivera H, Valero L, Escalona L, Roja-Sánchez F, Ríos M. Manejo multidisciplinario del paciente diagnosticado con el síndrome de Sjögren. Act Odontol Ven. 2009; 47 (3): 1-23.

  7. Kassan S , Moutsopoulos H. Clinical Manifestations and Early Diagnosis of Sjögren Syndrome. Arch Intern Med. 2004; 164: 1275-1284.

  8. Barker. B., Moffitt M., Johnson J. Sjögren’s syndrome: Diagnosis and dental treatment. J Prosthetic Dent. 1978; 38 (5): 536-538.

  9. Lafaurie G., Fedele S. , Granizo López R., Wolff A, Strietzel F., Porter S. Konttinen Y. Biotechnological advances in neuro-electro-stimulation for the treatment of hyposalivation and xerostomia. Med Oral Patol Oral Cir Bucal. 2009; 14 (2): E76-E80.

  10. Gonzalez S, Sung H, Sepúlveda D, Gonzalez M, Molina C. Oral manifestations and their treatment in Sjögren´s syndrome. Oral Dis. 2013 Mar 18. doi: 10.1111/odi.12105. [Epub ahead of print].

  11. Soto-Rojas A, Kraus A. The oral side of Sjögren syndrome. Diagnosis and treatment. A review. Arch Med Res. 2002; 33: 95–106.

  12. Armitage, G. Development of a Classification System for Periodontal Diseases and Conditions. Ann Periodontol. 1999; 4: 1–6.

  13. Chiche G, Pinault A. Prótesis fija estética en dientes anteriores. Editorial Masson 2008.

  14. Levin L. et al. Diagnostic Terms for Pulpal Health and Disease States. J Endod. 2009 Dec;35(12):1645-57.

  15. Chevingy C. et al. Treatment Outcome in Endodontics: The Toronto Study Phase 4: Initial Treatment. JOE. 2008; 34: 258–263.

  16. McGuire M. and Nunn M. Prognosis versus actual outcome. II. The effectiveness of clinical parameters in developing an accurate prognosis. J Periodontol. 1996; 67: 658-665.

  17. Zimmer S, Jahn K, Barthel C. Recommendations for the use of fluoride in caries prevention. Oral Health Prev Dent. 2003; 1: 45-51.

  18. Ong M, Tseng S, Wang H. Crown lengthening revisited. Clin Adv Periodontics. 2011; 1: 233-239.

  19. Daniels TE. Sjögren’s syndrome: clinical spectrum and current diagnostic controversies. Adv Dent Res. 1996; 10: 3-8.

  20. Manthorpe R. Sjögren’s syndrome criteria. Ann Rheum Dis. 2002; 61: 482.

  21. Scully C, Felix HD. Update for the dental practitioner, dry mouth and disorders of salivation. British Dental Journal. 2005; 199: 423-427.

  22. Boutsi E, Paikos S, Dafni U, Moutsopoulos H, Skopouli H. Dental and periodontal status of Sjögren’s syndrome. J Clin Periodontol. 2000; 27: 231–235.

  23. Ship J. Diagnosing, managing, and preventing salivary gland disorders. Oral Diseases. 2002; 8: 77-89.

  24. López P, Camacho F, Rodriguez C, Andujar P. Effectiveness of a motivational-behavioral skills protocol for oral hygiene among patients with hyposalivation. Gerodontology. 2013 Mar 9. doi: 10.1111/ger.12037. [Epub ahead of print].




2020     |     www.medigraphic.com